id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0093-0016,FDA,FDA-2013-N-0093,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2022-10-28T04:00:00Z,2022,10,2022-10-28T04:00:00Z,,2022-10-28T18:57:11Z,2022-23510,0,0,0900006485462fa0
FDA-2013-N-0093-0015,FDA,FDA-2013-N-0093,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Review Transparency and Communication for New Molecular Entity New Drug Applications and Original Biologics License Applications in Prescription
Drug User Fee Submissions",Notice,30 Day Proposed Information Collection,2022-08-29T04:00:00Z,2022,8,2022-08-29T04:00:00Z,2022-09-29T03:59:59Z,2022-08-29T19:29:38Z,2022-18546,0,0,09000064852853f4
FDA-2013-N-0093-0014,FDA,FDA-2013-N-0093,"Agency Information Collection Activities; Proposed Collection; Comment Request; New Molecular Entity New Drug Applications and Original Biologics License 
Applications",Notice,60 Day Proposed Information Collection,2022-03-21T04:00:00Z,2022,3,2022-03-21T04:00:00Z,2022-05-21T03:59:59Z,2022-08-29T19:25:19Z,2022-05814,0,0,0900006484fd6a0a